Dr. Bombay Ice Cream Custom Case Solution & Analysis

1. Evidence Brief — Business Case Data Researcher

Financial Metrics

• Revenue: $4.5M (FY2024, Exhibit 1).
• Gross Margin: 38% (Exhibit 1).
• Operating Profit: $320K (Exhibit 1).
• Customer Acquisition Cost (CAC): $14.20 per unit (Exhibit 3).
• Lifetime Value (LTV): Estimated at $42.00 over 3 years (Exhibit 3).

Operational Facts

• Manufacturing: Single facility in Pune, operating at 82% capacity (Para 14).
• Distribution: 60% of sales via direct-to-consumer (DTC) portal; 40% retail partnerships (Para 18).
• Headcount: 42 full-time employees (Exhibit 4).

Stakeholder Positions

• CEO (Arjun Bombay): Favors aggressive national expansion via retail chains.
• CFO (Meera Nair): Concerned about cash burn and debt-to-equity ratio (Para 22).
• Investors: Demanding 20% year-over-year growth (Para 25).

Information Gaps

• Shelf-life stability data for cold-chain expansion beyond Tier-1 cities.
• Detailed breakdown of marketing spend effectiveness between social media and local activations.

2. Strategic Analysis — Market Strategy Consultant

Core Strategic Question

• How to scale Dr. Bombay Ice Cream to meet investor growth targets while maintaining 38% gross margins and preventing liquidity depletion.

Structural Analysis

• Porter Five Forces: High buyer power in retail; intense rivalry from legacy incumbents (Amul, Kwality Walls).
• Value Chain: The current DTC-heavy model is capital-light but fails to capture the high-volume retail segment necessary for scale.

Strategic Options

• Option 1: Aggressive Retail Expansion. Target 500 new retail points. Trade-offs: High upfront listing fees, margin compression (to 30%), inventory risk.
• Option 2: Optimized DTC and Premium Niche. Focus on high-margin D2C subscriptions in Tier-1 metros. Trade-offs: Slower growth, lower capital expenditure, limits total addressable market.
• Option 3: Hybrid Franchise Model. Partner with regional distributors for cold-chain management. Trade-offs: Shared revenue, loss of brand control, faster regional penetration.

Preliminary Recommendation

• Pursue Option 3. It mitigates the capital risk of owning cold-chain logistics while achieving the reach required for 20% growth.

3. Implementation Roadmap — Operations and Implementation Planner

Critical Path

• Month 1-2: Audit regional distributors for cold-chain compliance.
• Month 3-4: Pilot program in two major metros (Mumbai/Bangalore).
• Month 5-6: Scale distribution based on sell-through velocity.

Key Constraints

• Cold-chain infrastructure reliability (failure leads to product spoilage).
• Working capital cycles for retail payments (typically 60-90 days).

Risk-Adjusted Implementation

• Establish a 15% contingency fund for logistics disruptions.
• Retain control over final-mile delivery quality to ensure brand consistency.

4. Executive Review and BLUF — Senior Partner

BLUF

• Dr. Bombay is at a crossroads. The current DTC-retail mix is insufficient to meet investor demands without eroding cash reserves. The recommended franchise model is the only path that balances capital preservation with necessary scale. However, the plan ignores the primary threat: incumbent retaliation. Legacy players possess massive distribution networks that can squeeze Dr. Bombay out of shelf space. We must prioritize high-traffic, exclusive retail partnerships over broad distribution to protect brand equity. Approval granted contingent on a revised retail strategy that favors density over reach.

Dangerous Assumption

• The assumption that regional distributors can maintain the same quality standards as the Pune facility. Failure here destroys the premium brand position.

Unaddressed Risks

• Regulatory: Food safety compliance across multiple state lines.
• Competitive: Incumbents using aggressive pricing to force us out of retail coolers.

Unconsidered Alternative

• Private-label manufacturing for high-end supermarkets. This provides immediate volume without the marketing expense of the Dr. Bombay brand, acting as a cash-flow bridge.

Verdict

• APPROVED FOR LEADERSHIP REVIEW (with the caveat that the retail strategy focuses on density).